Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease

  • M. Farallo U.O. Pediatria 2, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • C. Amoruso U.O. Pediatria 2, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • C. Frattini U.O. Pediatria 2, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • G. Ardissino U.O. Nefrologia e Dialisi Pediatrica - Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • G. Nebbia | gabriella.nebbia@policlinico.mi.it U.O. Pediatria 2, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy.

Abstract

We describe a case of nephrotic syndrome (NS) after a 7 months treatment with D-penicillamine in a 14 years old girl with Wilson’s disease , with a prompt regression at the discontinuation of the drug. Kidney function, proteinuria in particular, must be always monitored during the chelating therapy, and the drug must be discontinued as soon as signs of renal injury are detected.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2012-10-31
Info
Issue
Section
Articles
Keywords:
D-penicillamine, nephrotic syndrome, proteinuria, Wilson’s disease, children, copper metabolism
Statistics
  • Abstract views: 734

  • PDF: 921
How to Cite
Farallo, M., Amoruso, C., Frattini, C., Ardissino, G., & Nebbia, G. (2012). Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease. La Pediatria Medica E Chirurgica, 34(5). https://doi.org/10.4081/pmc.2012.60